Antisense inhibition of integrin beta 3 expression

Details Antisense inhibition of integrin beta 3 expression Antisense inhibition of integrin beta 3 expression

1999-06-25

2000-03-14

LeGuyader, John L.

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

435 6, 435 911, 435325, 435366, 435455, 536 231, 536 2431, 536 2433, 536 245, C12Q 168, C12N 1500, C07H 2104

Patent

active

060371765

ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of integrin beta 3. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding integrin beta 3. Methods of using these compounds for modulation of integrin beta 3 expression and for treatment of diseases associated with expression of integrin beta 3 are provided.

REFERENCES:
patent: 5578704 (1996-11-01), Kim et al.
patent: 5652109 (1997-07-01), Kim et al.
patent: 5652110 (1997-07-01), Kim et al.
patent: 5661005 (1997-08-01), Shattil et al.
patent: 5801154 (1998-09-01), Baracchini et al.
Dallahrida et al. FASEB Journal. 12(8):pA1346, Apr. 24, 1998.
Dallahrida et al. Blood 90(10), Suppl. 1 (Part 1 of 2), p286a, 1261, Nov. 15, 1997.
James, W. Antiviral Chemistry Chemotherapy 2:191-214 (1991).
Kumer et al. J. Biol. Chem. 272(26):16390-16397, 1997.
Milner et al. Nature Biotechnology 15:537-541, Jun. 1997.
Branch TIBS 23:45-50 1998.
Crooke S.T. ed. "Antisense Research and Application", Ch1, pp. 1-50, Springer-Verlag, New York 1998.
Akiyama, Integrins in cell adhesion and signaling, Hum. Cell, 1996, 9:181-186.
Cheresh, Structure, function and biological properties of integrin alpha v beta 3 on human melanoma cells, Cancer Metastasis Rev., 1991, 10:3-10.
Clemetson et al., Integrins and cardiovascular disease, Cell. Mol. Life Sci., 1998, 54:502-513.
Elangbam et al., Cell adhesion molecules--undate, Vet. Pathol., 1997, 34:61-73.
Horton, The alpha v beta 3 integrin "vitronectin receptor", Int. J. Biochem. Cell. Biol., 1997, 29:721-725.
Kato, The biologic and clinical spectrum of Glanzmann's thrombasthenia: implications of integrin alpha IIb beta 3 for its pathogenesis, Crit. Rev. Oncol. Hematol., 1997, 26:1-23.
LaFlamme et al., Integrin cytoplasmic domains as connectors to the cell's signal tranduction apparatus, Matrix Biol., 1997, 16:153-163.
Rodan et al., Integrin function in osteoclasts, J. Endocrinol., 1997, 154 Suppl:S47-56.
Ruoslahti, Integrins as signaling molecules and targets for tumor therapy, Kidney Int., 1997, 51:1413-1417.
Shattil, Regulation of platelet anchorage and signaling by integrin alpha IIb beta 3, Thromb. Haemost., 1993, 70:224-228.
Trikha et al., Human prostate carcinoma cells express functional alphaIIb (beta) 3 integrin, Cancer Res., 1996, 56:5071-5078.

Affiliated with

Also associated with

Rating

Antisense inhibition of integrin beta 3 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense inhibition of integrin beta 3 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense inhibition of integrin beta 3 expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-168532